v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Grant revenue $ 0 $ 763
Collaboration revenue - related party 258 5,099
Collaboration revenue $ 0 $ 12
Type of Revenue [Extensible List] us-gaap:LicenseMember us-gaap:LicenseMember
Total revenues $ 258 $ 5,874
Operating expenses:    
Research and development 2,909 13,606
General and administrative 4,887 6,824
Restructuring 0 175
Total operating expenses 7,796 20,605
Loss from operations (7,538) (14,731)
Other income (expense):    
Interest income 336 864
Other income (expense), net (1) 1
Total other income (expense), net 335 865
Net loss and comprehensive loss $ (7,203) $ (13,866)
Net loss per share attributable to common stockholders, basic $ (0.13) $ (0.25)
Net loss per share attributable to common stockholders, diluted $ (0.13) $ (0.25)
Weighted average common shares outstanding, basic 57,281,570 55,376,188
Weighted average common shares outstanding, diluted 57,281,570 55,376,188